Literature DB >> 26693168

13C Tracer Studies of Metabolism in Mouse Tumor Xenografts.

Andrew N Lane1, Jun Yan2, Teresa W-M Fan1.   

Abstract

Mice are widely used for human tumor xenograft studies of cancer development and drug efficacy and toxicity. Stable isotope tracing coupled with metabolomic analysis is an emerging approach for assaying metabolic network activity. In mouse models there are several routes of tracer introduction, which have particular advantages and disadvantages that depend on the model and the questions addressed. This protocol describes the bolus i.v. route via repeated tail vein injections of solutions of stable isotope enriched tracers including 13C6-glucose and 13C5,15N2-glutamine. Repeated injections give higher enrichments and over longer labeling periods than a single bolus. Multiple injections of glutamine are necessary to achieve adequate enrichment in engrafted tumors.

Entities:  

Year:  2015        PMID: 26693168      PMCID: PMC4675468          DOI: 10.21769/bioprotoc.1650

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  11 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  A rapid, simple, and humane method for submandibular bleeding of mice using a lancet.

Authors:  William T Golde; Peter Gollobin; Luis L Rodriguez
Journal:  Lab Anim (NY)       Date:  2005-10       Impact factor: 12.625

3.  Isotopomer-based metabolomic analysis by NMR and mass spectrometry.

Authors:  Andrew N Lane; Teresa W-M Fan; Richard M Higashi
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

4.  Stable isotope resolved metabolomics of lung cancer in a SCID mouse model.

Authors:  Teresa W-M Fan; Andrew N Lane; Richard M Higashi; Jun Yan
Journal:  Metabolomics       Date:  2011-06-01       Impact factor: 4.290

Review 5.  State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide.

Authors:  Robin A de Graaf; Douglas L Rothman; Kevin L Behar
Journal:  NMR Biomed       Date:  2011-08-23       Impact factor: 4.044

6.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

Authors:  Isaac Marin-Valencia; Chendong Yang; Tomoyuki Mashimo; Steve Cho; Hyeonman Baek; Xiao-Li Yang; Kartik N Rajagopalan; Melissa Maddie; Vamsidhara Vemireddy; Zhenze Zhao; Ling Cai; Levi Good; Benjamin P Tu; Kimmo J Hatanpaa; Bruce E Mickey; José M Matés; Juan M Pascual; Elizabeth A Maher; Craig R Malloy; Ralph J Deberardinis; Robert M Bachoo
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

Review 7.  Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer.

Authors:  Andrew N Lane; Teresa W-M Fan; Michael Bousamra; Richard M Higashi; Jun Yan; Donald M Miller
Journal:  OMICS       Date:  2011-02-17

8.  Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation.

Authors:  Katherine Sellers; Matthew P Fox; Michael Bousamra; Stephen P Slone; Richard M Higashi; Donald M Miller; Yali Wang; Jun Yan; Mariia O Yuneva; Rahul Deshpande; Andrew N Lane; Teresa W-M Fan
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

9.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

10.  Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.

Authors:  Han Xie; Jun-Ichi Hanai; Jian-Guo Ren; Lev Kats; Kerri Burgess; Parul Bhargava; Sabina Signoretti; Julia Billiard; Kevin J Duffy; Aaron Grant; Xiaoen Wang; Pawel K Lorkiewicz; Sabrina Schatzman; Michael Bousamra; Andrew N Lane; Richard M Higashi; Teresa W M Fan; Pier Paolo Pandolfi; Vikas P Sukhatme; Pankaj Seth
Journal:  Cell Metab       Date:  2014-04-10       Impact factor: 27.287

View more
  13 in total

1.  Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).

Authors:  Andrew N Lane; Richard M Higashi; Teresa W-M Fan
Journal:  Metabolomics       Date:  2016-06-29       Impact factor: 4.290

2.  Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics.

Authors:  Andrew N Lane; Julie Tan; Yali Wang; Jun Yan; Richard M Higashi; Teresa W-M Fan
Journal:  Metab Eng       Date:  2017-02-02       Impact factor: 9.783

3.  The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis.

Authors:  Eunus S Ali; Anna Lipońska; Brendan P O'Hara; David R Amici; Michael D Torno; Peng Gao; John M Asara; Mee-Ngan F Yap; Marc L Mendillo; Issam Ben-Sahra
Journal:  Mol Cell       Date:  2022-06-29       Impact factor: 19.328

4.  Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling.

Authors:  Daniela Gaglio; Marcella Bonanomi; Silvia Valtorta; Rohit Bharat; Marilena Ripamonti; Federica Conte; Giulia Fiscon; Nicole Righi; Elisabetta Napodano; Federico Papa; Isabella Raccagni; Seth J Parker; Ingrid Cifola; Tania Camboni; Paola Paci; Anna Maria Colangelo; Marco Vanoni; Christian M Metallo; Rosa Maria Moresco; Lilia Alberghina
Journal:  Cancer Metab       Date:  2020-09-29

5.  Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS/MS.

Authors:  Min Yuan; Daniel M Kremer; He Huang; Susanne B Breitkopf; Issam Ben-Sahra; Brendan D Manning; Costas A Lyssiotis; John M Asara
Journal:  Nat Protoc       Date:  2019-02       Impact factor: 13.491

6.  Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition.

Authors:  Alexander Muir; Laura V Danai; Dan Y Gui; Chiara Y Waingarten; Caroline A Lewis; Matthew G Vander Heiden
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

7.  Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models.

Authors:  Jinny Sun; Robert A Bok; Justin DeLos Santos; Deepti Upadhyay; Romelyn DeLos Santos; Shubhangi Agarwal; Mark Van Criekinge; Daniel B Vigneron; Rahul Aggarwal; Donna M Peehl; John Kurhanewicz; Renuka Sriram
Journal:  Metabolites       Date:  2021-02-26

8.  Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma.

Authors:  Samuel K McBrayer; Jared R Mayers; Gabriel J DiNatale; Diana D Shi; Januka Khanal; Abhishek A Chakraborty; Kristopher A Sarosiek; Kimberly J Briggs; Alissa K Robbins; Tomasz Sewastianik; Sarah J Shareef; Benjamin A Olenchock; Seth J Parker; Kensuke Tateishi; Jessica B Spinelli; Mirazul Islam; Marcia C Haigis; Ryan E Looper; Keith L Ligon; Bradley E Bernstein; Ruben D Carrasco; Daniel P Cahill; John M Asara; Christian M Metallo; Neela H Yennawar; Matthew G Vander Heiden; William G Kaelin
Journal:  Cell       Date:  2018-09-13       Impact factor: 41.582

Review 9.  Resolving Metabolic Heterogeneity in Experimental Models of the Tumor Microenvironment from a Stable Isotope Resolved Metabolomics Perspective.

Authors:  Teresa W-M Fan; Richard M Higashi; Yelena Chernayavskaya; Andrew N Lane
Journal:  Metabolites       Date:  2020-06-15

10.  Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo.

Authors:  Lindsey R Conroy; Susan Dougherty; Traci Kruer; Stephanie Metcalf; Pawel Lorkiewicz; Liqing He; Xinmin Yin; Xiang Zhang; Sengodagounder Arumugam; Lyndsay E A Young; Ramon C Sun; Brian F Clem
Journal:  Cancers (Basel)       Date:  2020-01-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.